Direct From China Factory 99% Purity Peptide Ss-31 10mg/50mg Best Price Bulk Order
Reagent Grade
99%
Shenzhen, Shanghai
T&L
10 Vials per Kit
2026-11-14
Peptide,Pharmaceutical raw powder
-
Product Description
-
Seller Information
-
DescriptionBasic Info
-
Product Name:
SS-31
Categories:
Research-
Class:
Mitochondria-targeted tetrapeptide (Szeto-Schiller peptide)
Status:FDA-approved (Forzinity) — Accelerated Approval 2025
Mechanism:A cell-permeable, synthetic tetrapeptide (D-Arg-Dmt-Lys-Phe-NH₂) that selectively concentrates in the inner mitochondrial membrane and reversibly binds to cardiolipin, a phospholipid essential for electron transport chain (ETC) function. By stabilizing cardiolipin, SS-31 restores mitochondrial bioenergetics, reduces cytochrome c peroxidase activity, and prevents oxidative damage in cells with impaired mitochondrial function.
Activity note:SS-31 does not act via traditional receptor agonism. It binds cardiolipin with high selectivity in the inner mitochondrial membrane. Functional EC₅₀ values are context-dependent (cell type, stress model). Key electrophysiology studies report mitochondrial membrane potential restoration at nanomolar concentrations.
Source:Szeto HH, et al. AAPS J. 2006;8(2):E277-E283. Birk AV, et al. J Am Soc Nephrol. 2014;25(6):1157-1169.DOI
Clinical Development:FDA:Forzinity (approved 2025-09-19)
References-
ChEMBL:DrugBank:KEGG DRUG:PubChem:Literature:
FDA: Forzinity (NDA 215244) — Accelerated Approval 2025; Genetics in Medicine: TAZPOWER Phase 2/3 results (Thompson et al. 2020); Drugs: Elamipretide First Approval (Springer 2025)
Disclaimer:Elamipretide (Forzinity) is FDA-approved under accelerated approval for Barth syndrome. This listing is for industrial and laboratory research use only. Research-chemical listings on B2B marketplaces are not interchangeable with approved medicines. Confirm CAS, specification, and regulatory pathway with the seller. It is not medical advice, a clinical recommendation, or an approved therapy description.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Peptide,Pharmaceutical raw powder
-
Location:
No. 188 Kaiyuan Avenue, Science City, Guangzhou High-tech Industrial Development Zone, Huangpu District, Guangzhou
-
Payment Terms:
100% TT in advance
-
Average lead Time:
15
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
11-50
-
Year of Establishment:
2020
-
-
Country Product Purchase Quantity Date Posted Post an enquiry for this product
- Hot Searches
- sodium lauryl sulfate sds
- trisodium phosphate where to buy
- where to buy reta peptide
- ferric chloride market
- dihexa peptide buy online
- price of phosphorus
- teriparatide injection
- sr17018 for sale
- where to buy anhydrous ammonia
- price of base oil
- dibasic calcium phosphate
- sodium benzoate vs benzoic acid